Weitzman SA - Search Results

1

Cisplatin-vincristine-bleomycin therapy in squamous cell carcinoma of the head and neck.

Amrein PC, Fingert H, Weitzman SA. Amrein PC, et al. Among authors: weitzman sa. J Clin Oncol. 1983 Jul;1(7):421-7. doi: 10.1200/JCO.1983.1.7.421. J Clin Oncol. 1983. PMID: 6199477

2

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.

Amrein PC, Weitzman SA. Amrein PC, et al. Among authors: weitzman sa. J Clin Oncol. 1985 Dec;3(12):1632-9. doi: 10.1200/JCO.1985.3.12.1632. J Clin Oncol. 1985. PMID: 2415693

3

Comparison of filtration leukapheresis and centrifugation leukapheresis in treatment of lymphosarcoma cell leukemia.

Amrein PC, Kumar JR, Poulin RF, Umlas J, Weitzman SA. Amrein PC, et al. Among authors: weitzman sa. South Med J. 1982 Aug;75(8):969-71. doi: 10.1097/00007611-198208000-00016. South Med J. 1982. PMID: 7112205

4

Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.

Laver JH, Mahmoud H, Pick TE, Hutchison RE, Weinstein HJ, Schwenn M, Weitzman S, Murphy SB, Ochoa S, Shuster JJ. Laver JH, et al. Leuk Lymphoma. 2002 Jan;43(1):105-9. doi: 10.1080/10428190210192. Leuk Lymphoma. 2002. PMID: 11908712 Clinical Trial.

5

Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group study.

Laver JH, Mahmoud H, Pick TE, Hutchinson RE, Weinstein HJ, Schwenn M, Weitzman S, Murphy SB, Ochoa S, Shuster JJ; Pediatric Oncology Group. Laver JH, et al. Leuk Lymphoma. 2001 Jul;42(3):399-405. doi: 10.3109/10428190109064597. Leuk Lymphoma. 2001. PMID: 11699405 Clinical Trial.

6

Development of MAPT S305 mutation human iPSC lines exhibiting elevated 4R tau expression and functional alterations in neurons and astrocytes.

Bowles KR, Pedicone C, Pugh DA, Oja LM, Sousa FH, Keavey LK, Fulton-Howard B, Weitzman SA, Liu Y, Chen JL, Disney MD, Goate AM. Bowles KR, et al. Among authors: weitzman sa. Cell Rep. 2024 Nov 26;43(12):115013. doi: 10.1016/j.celrep.2024.115013. Online ahead of print. Cell Rep. 2024. PMID: 39602304 Free article.

7

Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.

Pedicone C, Weitzman SA, Renton AE, Goate AM. Pedicone C, et al. Among authors: weitzman sa. Mol Neurodegener. 2024 May 29;19(1):43. doi: 10.1186/s13024-024-00731-x. Mol Neurodegener. 2024. PMID: 38812061 Free PMC article. Review.

8

Development of MAPT S305 mutation models exhibiting elevated 4R tau expression, resulting in altered neuronal and astrocytic function.

Bowles KR, Pugh DA, Pedicone C, Oja L, Weitzman SA, Liu Y, Chen JL, Disney MD, Goate AM. Bowles KR, et al. Among authors: weitzman sa. bioRxiv [Preprint]. 2023 Jun 5:2023.06.02.543224. doi: 10.1101/2023.06.02.543224. bioRxiv. 2023. PMID: 37333200 Free PMC article. Preprint.

9

Automated vision screening of children using a mobile graphic device.

Kane SA, Gaspich M, Kane J, Weitzman SA, Hofeldt A. Kane SA, et al. Among authors: weitzman sa. Eye (Lond). 2023 Jan;37(1):30-33. doi: 10.1038/s41433-021-01862-x. Epub 2021 Dec 6. Eye (Lond). 2023. PMID: 34873296 Free PMC article.

10

Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo.

Weitzman SA, Narasimhan S, He Z, Changolkar L, McBride JD, Zhang B, Schellenberg GD, Trojanowski JQ, Lee VMY. Weitzman SA, et al. J Neuropathol Exp Neurol. 2020 Sep 1;79(9):941-949. doi: 10.1093/jnen/nlaa086. J Neuropathol Exp Neurol. 2020. PMID: 32838419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters